Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Citi
QuintilesIMS
Medtronic
Express Scripts

Generated: March 26, 2019

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

When do Cleocin patents expire, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.

Drug patent expirations by year for CLEOCIN
Pharmacology for CLEOCIN
Synonyms for CLEOCIN
(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride
(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-|A-D-galactooctopyranoside Hydrochloride
(2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDE HYDROCHLORIDE
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
17431-55-9
18323-44-9 (Parent)
21462-39-5
26884-28-6
32795-16-7
462C395
58207-19-5
7-Epi Clindamycin Hydrochloride
AB0071584
AB43001
AC-12179
AC1O4WFR
ACT02688
AKOS015843964
AKOS015960823
Antibiotic U 21251F Hydrochloride
Antirobe
Antirobe vet.
API0002053
AS-13649
AT-13884
AUODDLQVRAJAJM-XJQDNNTCSA-N
BCP11950
BenzaClin
BIC0117
C13684
CAS-21462-39-5
CC0172
CCG-212538
CHEMBL1200588
CHEMBL1452303
Cleocin HCl
Cleocin hydrochloride
Cleocin hydrochloride (TN)
Clindamycin (hydrochloride)
CLINDAMYCIN ALCOHOLATE
Clindamycin Hcl
Clindamycin HCl (Dalacin)
Clindamycin hydrochloride
Clindamycin hydrochloride (JP17/USP)
Clindamycin hydrochloride [USP:BAN:JAN]
clindamycin hydrochloride hydrochloride
Clindamycin hydrochloride monohydrate
Clindamycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Clindamycin hydrochloride, lincosamide antibiotic
Clindimycin hydrochloride
Clinsol
Clintabs
CS-2508
D02132
Dalacin (TN)
DSSTox_CID_25428
DSSTox_GSID_45428
DSSTox_RID_80872
DTXSID4045428
EC 244-398-6
HMS1568K16
HY-B0408A
J10047
MCULE-6809905039
Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-1-thiooctopyranoside (HCl)
Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride
Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride
MFCD03253991
MFCD07793327
MFCD07793327 (97+%)
MLS000069765
MolPort-003-983-294
NCGC00016752-01
NSC-305832
NSC-756696
NSC305832
NSC756696
Pharmakon1600-01500193
Prestwick_69
SCHEMBL3153
SMR000058902
SR-01000722035
SR-01000722035-3
ST2406750
SY006928
T20OQ1YN1W
Tox21_110591
U 21251F
U-25179E
UNII-T20OQ1YN1W
Z-4007
ZX-AFC000484

US Patents and Regulatory Information for CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CLEOCIN clindamycin hydrochloride CAPSULE;ORAL 061809-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CLEOCIN T clindamycin phosphate GEL;TOPICAL 050615-001 Jan 7, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767-001 Aug 13, 1999 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for CLEOCIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 2013C/060 Belgium ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1304992 C300617 Netherlands ➤ Try a Free Trial PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992 PA2013025,C1304992 Lithuania ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Deloitte
Cantor Fitzgerald
Baxter
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.